Clinical Use of Artificial Oxygen Carriers
Artificial oxygen carriers aim at improving oxygen delivery (DO2). Artificial oxygen carriers, therefore, may be used as an alternative to allogeneic blood transfusions or to improve tissue oxygenation and function of organs with marginal oxygen supply [1, 2]. Modified hemoglobin solutions and perfluorocarbon (PFC) emulsions are currently undergoing clinical testing. This chapter is based on a recent review article  where more detailed references may be found. Current knowledge of artifical oxygen carriers is based on published data from approximately 500–1000 patients treated with these compounds and a similar number of control patients. Unfortunately, there is still a significant amount of non-published data that renders the overall assessment of these solutions difficult.
KeywordsIschemia Lactate Bromide Lipase Anemia
Unable to display preview. Download preview PDF.
- 3.Spahn DR, Kocian R (2003) Place of artifical oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation. Can J Anaesth (in press)Google Scholar
- 7.Sloan EP, Koenigsberg M, Gens D, et al (19999) Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 282: 1857–1864Google Scholar
- 10.Carmichael FJ, Biro GP, Cheng DC (2001) Phase III clinical trial of hemolink in conjunction with intraoperative autologous donation (IAD) in cardiac surgical patients. Artif Cells Blood Substit Immobil Biotechnol 29: 102 (abst)Google Scholar
- 11.Jahr JS (2001) A novel blood substitute: Use of HBOC-201 (Hemopure) to decrease need for RBC: Results of pivotal trail in orthopedic surgery patients. Crit Care Med 29 (suppl): A160 (abst)Google Scholar
- 13.Cheng DC, Martineau R, MacAdams C, et al (2001) Safety of Hemolink as an oxygen therapeutic in patients undergoing coronary artery bypass graft surgery. Anesth Analg 92 (suppl):SCA3 (abst)Google Scholar
- 14.Jahr JS, Stewart LM, MacKenzie C, Bourke D, williams JP (2002) Pivotal phase III study: safety of polymerized bovine hemoglobin (HBOC-201, Hemopure) as compared to RBC in patients undergoing orthopedic surgery. Anesthesiology 96: A243 (abst)Google Scholar